Clinical Trial Highlights

• Optimal Dosing and Titration of U-500R Improve Glycemic Control
• The PAOLA Study
• Biochemical Control of Acromegaly Continued in PAOLA Trial Extension
• Early Initiation of Low-Dose Levothyroxine After Radioactive Iodine Appears Safe
• DREAM
• VIDOS
• Liraglutide Leads to Increased Weight Loss Response in Patients Without Diabetes
• Significant HbA_1c Reduction With Empagliflozin/Linagliptin Combination
• ATL1103 Effective in Reducing IGF-1 Levels in Patients With Acromegaly
• Increased TSH Levels Do Not Affect Safety, Efficacy in Refractory Thyroid Cancer
• Liraglutide, Roflumilast Improve Body Weight in Obese Women With PCOS
• LH and Testosterone Significantly Reduced With NKB Receptor Antagonist in PCOS
• Improvements in Diabetes Control Similar in Patients Who Undergo LAGB or Intensive Management
• Calcium Supplementation and Hyperabsorption Lead to Hypercalcemia and Hypercalciuria